FTSE 100
|
10 292,16
|
31,01
|
0,30 %
|
Analysen zu FTSE 100-Werten
| 30.01.25 | Shell Buy | Jefferies & Company Inc. | |
| 30.01.25 | Shell Outperform | RBC Capital Markets | |
| 30.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | GSK Neutral | UBS AG | |
| 30.01.25 | AstraZeneca Neutral | UBS AG | |
| 30.01.25 | Shell Outperform | RBC Capital Markets | |
| 30.01.25 | Shell Buy | UBS AG | |
| 30.01.25 | Shell Buy | Goldman Sachs Group Inc. | |
| 28.01.25 | Shell Outperform | RBC Capital Markets | |
| 28.01.25 | BAT Buy | Deutsche Bank AG | |
| 27.01.25 | Diageo Buy | Jefferies & Company Inc. | |
| 27.01.25 | Diageo Sector Perform | RBC Capital Markets | |
| 27.01.25 | Diageo Buy | UBS AG | |
| 24.01.25 | Diageo Buy | UBS AG | |
| 24.01.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 24.01.25 | Rio Tinto Neutral | UBS AG | |
| 24.01.25 | BP Buy | UBS AG | |
| 24.01.25 | Shell Buy | UBS AG | |
| 24.01.25 | Diageo Outperform | Bernstein Research | |
| 23.01.25 | easyJet Buy | UBS AG | |
| 23.01.25 | Vodafone Group Underperform | Bernstein Research | |
| 23.01.25 | Unilever Overweight | JP Morgan Chase & Co. | |
| 23.01.25 | easyJet Buy | Deutsche Bank AG | |
| 23.01.25 | Vodafone Group Buy | Deutsche Bank AG | |
| 23.01.25 | Diageo Buy | UBS AG | |
| 23.01.25 | London Stock Exchange Buy | UBS AG | |
| 23.01.25 | easyJet Market-Perform | Bernstein Research | |
| 22.01.25 | easyJet Neutral | Goldman Sachs Group Inc. | |
| 22.01.25 | BP Sector Perform | RBC Capital Markets | |
| 22.01.25 | easyJet Sector Perform | RBC Capital Markets | |
| 22.01.25 | easyJet Buy | UBS AG | |
| 22.01.25 | Rolls-Royce Buy | Jefferies & Company Inc. | |
| 22.01.25 | London Stock Exchange Hold | Deutsche Bank AG | |
| 22.01.25 | easyJet Market-Perform | Bernstein Research | |
| 22.01.25 | BP Buy | UBS AG | |
| 22.01.25 | easyJet Overweight | JP Morgan Chase & Co. | |
| 21.01.25 | Vodafone Group Neutral | UBS AG | |
| 21.01.25 | RELX Overweight | JP Morgan Chase & Co. | |
| 21.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. |